Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.97
Delayed Data
As of May 26
 +0.03 / +1.02%
Today’s Change
1.65
Today|||52-Week Range
6.49
+70.69%
Year-to-Date

Today’s Trading

Previous close2.94
Today’s open2.92
Day’s range2.89 - 3.04
Volume41,442
Average volume (3 months)365,792
Market cap$44.8M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-495.83%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
CTRVContraVir Pharmaceut...-0.00-0.12%
GNMXAevi Genomic Medicin...-0.02-1.67%
OVASOvaScience Inc-0.02-1.53%
ITEKInotek Pharmaceutica...0.000.00%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$2.40
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts